{
    "nct_id": "NCT03480360",
    "official_title": "Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates Examining Checkpoint Immune Regulators' Expression",
    "inclusion_criteria": "* Age: less than 75 years\n* The patient must be approved for transplant by the treating transplant physician. This includes completion of their pre-transplant workup, as directed by standard Dartmouth-Hitchcock Medical Center (DHMC) Standard Operating Procedure (SOP) (DHMC SOP - Pre-transplant Evaluation of allogeneic recipient (Appendix).\n* The patient must have a disease (listed below) with treatment-responsiveness that the treating transplant physician believes will benefit from an allogeneic stem cell transplant. The diseases include:\n* Acute leukemia - Acute Myeloid Leukemia, Acute Lymphocytic Leukemia\n* Chronic leukemia - Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia\n* Myelodysplasia\n* Myeloproliferative disorder\n* Myelofibrosis\n* Lymphoma - Non-Hodgkin's Lymphoma or Hodgkin's disease\n* Plasma cell disorder, including myeloma, Waldenstrom's Macroglobulinemia\n* Donor availability- the patient must have an identified RELATED haplo-identical donor\n* No Human Immunodeficiency Virus infection or active hepatitis B or C\n* Eastern Cooperative Oncology Group performance status: 0-2\n* Diffusing capacity of carbon monoxide (DLCO) greater than or equal to 40 % predicted\n* Left ventricular ejection fraction greater than or equal to 40%\n* Serum bilirubin < 2x upper limit of normal; transaminases < 3x normal at the time of transplant\n* No active or uncontrollable infection\n* In female, a negative pregnancy test if experiencing menstrual periods\n* No major organ dysfunction precluding transplantation\n* No evidence of an active malignancy that would limit the patient's survival to less than 2 years. (If there is any question, the PI can make a decision).\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Psychiatric disorder or a mental deficiency of the patient that is sufficiently severe to make compliance with the treatment unlikely, and making informed consent impossible.\n* Major anticipated illness or organ failure incompatible with survival from bone marrow transplant.\n* History of refractory systemic infection\n\nDONOR ELIGIBILITY\n\n* Human leukocyte antigen (HLA) haplo-identical matched related.\n* The donor must be healthy and must be willing to serve as a donor, based on standard National Marrow Donor Program (NMDP) guidelines and DHMC SOP - Donor Evaluation (Appendix)\n* The donor must have no significant co-morbidities that would put the donor at marked increased risk\n* There is no age restriction for the donor\n* Informed consent must be signed by donor\n\nDONOR EXCLUSION CRITERIA\n\n* The NMDP guidelines for exclusion criteria will be used (Appendix). In addition, the following donors are NOT eligible:\n* Pregnant or lactating donor\n* HIV or active Hep B or C in the donor\n* Donor unfit to receive G-CSF and undergo apheresis\n* A donor with a psychiatric disorder or mental deficiency that makes compliance with the procedure unlikely and informed consent impossible",
    "miscellaneous_criteria": ""
}